Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3588911
Max Phase: Preclinical
Molecular Formula: C15H21N3
Molecular Weight: 243.35
Molecule Type: Small molecule
Associated Items:
ID: ALA3588911
Max Phase: Preclinical
Molecular Formula: C15H21N3
Molecular Weight: 243.35
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1ccccc1Cn1ccnc1CNC(C)C
Standard InChI: InChI=1S/C15H21N3/c1-12(2)17-10-15-16-8-9-18(15)11-14-7-5-4-6-13(14)3/h4-9,12,17H,10-11H2,1-3H3
Standard InChI Key: IHXSUUAPXBDLCV-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 243.35 | Molecular Weight (Monoisotopic): 243.1735 | AlogP: 2.74 | #Rotatable Bonds: 5 |
Polar Surface Area: 29.85 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 8.11 | CX LogP: 2.72 | CX LogD: 1.93 |
Aromatic Rings: 2 | Heavy Atoms: 18 | QED Weighted: 0.87 | Np Likeness Score: -1.65 |
1. Szőllősi E, Bobok A, Kiss L, Vass M, Kurkó D, Kolok S, Visegrády A, Keserű GM.. (2015) Cell-based and virtual fragment screening for adrenergic α2C receptor agonists., 23 (14): [PMID:25648685] [10.1016/j.bmc.2015.01.013] |
Source(1):